Adastra Pharmaceuticals, Inc.

Morningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without

SHANGHAI - Shenzhen-listed Nantong Jinghua Pharmaceutical has acquired exclusive China rights to two humanized monoclonal antibodies (mAbs) for cancer from New York-based Kadmon Corp. LLC . The mov

Despite ambitions to become the “global category leader in oncology,” Astellas Pharma Inc. has decided to pull the plug on a promising collaboration in acute myeloid leukemia with privately held

Oncology-focused US biotech Polynoma, part of the Hong Kong company CK Life Sciences, has expanded its senior management team with three appointments: Dr Sara Zaknoen joins as chief medical officer, A